← back to search

Ju Guo

Nanchang University · CN
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Cancer research and Prostate cancer, with related work in Prostatectomy, Bladder cancer, Renal cell carcinoma. Notable publications include 'IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer', 'A comparison of the prognosis of papillary and clear cell renal cell carcinoma', and 'Combining Protein and miRNA Quantification for Bladder Cancer Analysis'.
h-index
citations
624
works
26
NIH funding
primary concept
email

Recent publications

Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME
Molecular Cancer 2025cited by 3position: lastdoi
USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer
Cell Death and Disease 2024cited by 10position: middledoi
A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling
Oncogene 2024cited by 4position: middledoi
CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia
Cell Death and Disease 2023cited by 9position: lastdoi
Initial experience and short-term outcomes of single-port extraperitoneal transvesical robot-assisted radical prostatectomy: a two-center study
Translational Andrology and Urology 2023cited by 6position: middledoi
Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions
Journal of Translational Medicine 2023cited by 3position: firstdoi
Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer
Cancer Letters 2022cited by 35position: middledoi
ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma
Journal of Cancer 2022cited by 19position: lastdoi
HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways
Journal of Cancer Research and Clinical Oncology 2022cited by 15position: lastdoi
Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma
Cell Transplantation 2022cited by 11position: lastdoi
A Nomogram Predicting Lymph Node Metastasis in Patients with Prostate Cancer Undergoing Ultrasound-Guided Transrectal Prostate Biopsy
Indian Journal of Surgery 2022cited by 2position: middledoi
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
Journal for ImmunoTherapy of Cancer 2021cited by 41position: middledoi
Independent Factors Affecting Postoperative Short-Term Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy
Journal of Oncology 2021cited by 25position: middledoi
Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up
Frontiers in Oncology 2021cited by 15position: middledoi
Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups
Frontiers in Oncology 2021cited by 15position: middledoi
Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
Cancer Medicine 2021cited by 10position: middledoi
IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer
Journal of Cellular and Molecular Medicine 2020cited by 147position: middledoi
Transvesical robot‐assisted radical prostatectomy: initial experience and surgical outcomes
British Journal of Urology 2020cited by 29position: middledoi
A comparison of the prognosis of papillary and clear cell renal cell carcinoma
Medicine 2019cited by 60position: middledoi
Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence
BioMed Research International 2019cited by 16position: lastdoi
Intraoperative serious complications of laparoscopic urological surgeries: a single institute experience of 4,380 procedures
International braz j urol 2019cited by 12position: firstdoi
Androgen receptor reverts dexamethasone‑induced inhibition of prostate cancer cell proliferation and migration
Molecular Medicine Reports 2018cited by 15position: firstdoi
Combining Protein and miRNA Quantification for Bladder Cancer Analysis
ACS Applied Materials & Interfaces 2017cited by 43position: middledoi
miR‑20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer
Oncology Letters 2017cited by 39position: firstdoi
MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion
Tumor Biology 2017cited by 17position: firstdoi
miR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells
International Journal of Oncology 2015cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bin Fu · Nanchang University11 papers (2015–2023)Luyao Chen · Nanchang University7 papers (2020–2023)Xiaoqiang Liu · Nanchang University6 papers (2021–2022)Wen Deng · Nanchang University6 papers (2021–2023)Gongxian Wang · Nanchang University5 papers (2020–2022)Jieping Hu · Nanchang University5 papers (2018–2022)Cheng Zhang · Guangdong Provincial People's Hospital4 papers (2020–2023)Weipeng Liu · Nanchang University4 papers (2021–2023)Xiaochen Zhou · Nanchang University4 papers (2020–2023)Ke Zhu · Nanchang University3 papers (2021–2021)Runfu Cao · Nanchang University3 papers (2017–2019)Jun Deng · Sun Yat-sen University3 papers (2018–2019)Qingke Chen · Nanchang University3 papers (2018–2019)Qiufeng Pan · Nanchang University2 papers (2022–2022)Xiaochen Zhou · Nanchang University2 papers (2021–2022)Sheng Li · Guangzhou University of Chinese Medicine2 papers (2024–2024)Lin Yang · Yunnan Agricultural University2 papers (2024–2024)Xu Zhang · Chinese PLA General Hospital2 papers (2020–2023)Jing Xiong · Nanchang University2 papers (2024–2024)Zhongqi Li · University of Florida2 papers (2024–2024)